Vera Bril

26.4k total citations · 5 hit papers
386 papers, 15.7k citations indexed

About

Vera Bril is a scholar working on Neurology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vera Bril has authored 386 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Neurology, 94 papers in Physiology and 74 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vera Bril's work include Myasthenia Gravis and Thymoma (133 papers), Peripheral Neuropathies and Disorders (119 papers) and Botulinum Toxin and Related Neurological Disorders (89 papers). Vera Bril is often cited by papers focused on Myasthenia Gravis and Thymoma (133 papers), Peripheral Neuropathies and Disorders (119 papers) and Botulinum Toxin and Related Neurological Disorders (89 papers). Vera Bril collaborates with scholars based in Canada, United States and Germany. Vera Bril's co-authors include Bruce A. Perkins, Eva L. Feldman, Rayaz A. Malik, Dan Ziegler, Andrew J.M. Boulton, Jay M. Sosenko, Roy Freeman, Rodica Pop‐Busui, Carolina Barnett and Hans Katzberg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Vera Bril

370 papers receiving 15.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

2016 1.6k citations Eva L. Feldman, Vera Bril et al. profile →
Diabetic Neuropathies

2005 1.4k citations Vera Bril, Eva L. Feldman et al. profile →
Diabetic neuropathy

2019 978 citations Eva L. Feldman, Douglas W. Zochodne et al. profile →
Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]

2011 449 citations Vera Bril, J. England et al. Neurology profile →
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

2024 36 citations Vera Bril, Tuan Vu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Vera Bril	8.4k	6.0k	3.0k	2.1k	2.1k	386	15.7k
Solomon Tesfaye	5.4k 0.6×	7.8k 1.3×	3.9k 1.3×	875 0.4×	959 0.5×	234	14.5k
Giuseppe Lauria	6.3k 0.7×	7.4k 1.2×	1.1k 0.4×	705 0.3×	3.6k 1.7×	250	14.3k
Dan Ziegler	5.8k 0.7×	8.0k 1.3×	4.0k 1.3×	851 0.4×	828 0.4×	274	17.9k
Rayaz A. Malik	6.7k 0.8×	10.3k 1.7×	5.1k 1.7×	4.3k 2.0×	1.4k 0.7×	548	24.8k
Roy Freeman	6.9k 0.8×	8.4k 1.4×	2.6k 0.9×	835 0.4×	2.0k 1.0×	206	19.5k
Aaron I. Vinik	7.0k 0.8×	7.4k 1.2×	6.2k 2.1×	1.3k 0.6×	1.3k 0.6×	420	24.1k
Rodica Pop‐Busui	3.0k 0.4×	5.0k 0.8×	5.1k 1.7×	689 0.3×	612 0.3×	228	13.6k
Henning Andersen	3.2k 0.4×	2.5k 0.4×	1.5k 0.5×	2.1k 1.0×	1.3k 0.6×	322	13.4k
Didier Leys	7.1k 0.8×	2.7k 0.4×	573 0.2×	1.9k 0.9×	860 0.4×	437	20.2k
James W. Albers	3.7k 0.4×	1.9k 0.3×	1.2k 0.4×	1.6k 0.7×	1.9k 0.9×	154	8.3k

Countries citing papers authored by Vera Bril

Since Specialization

Citations

This map shows the geographic impact of Vera Bril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Bril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Bril more than expected).

Fields of papers citing papers by Vera Bril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Bril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Bril. The network helps show where Vera Bril may publish in the future.

Co-authorship network of co-authors of Vera Bril

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Bril. A scholar is included among the top collaborators of Vera Bril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Bril. Vera Bril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Annane, Djillali, Andreas Meisel, Masahisa Katsuno, et al.. (2024). P.053 Concomitant corticosteroid use in ravulizumab-treated adults with anti-AChR antibody-positive gMG: results from the CHAMPION MG open-label extension. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51(s1). S30–S30. 1 indexed citations

Bril, Vera, et al.. (2024). Aging and infectious diseases in myasthenia gravis. Journal of the Neurological Sciences. 468. 123314–123314. 1 indexed citations

Katzberg, Hans, Vera Bril, Warren Mason, et al.. (2024). Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors. JTO Clinical and Research Reports. 6(5). 100772–100772.

Fathi, Davood, Ali Naraghi, Lawrence M. White, et al.. (2024). Whole‐body magnetic resonance neurography in patients with chronic inflammatory demyelinating polyneuropathy. Muscle & Nerve. 70(1). 101–110. 2 indexed citations

Bril, Vera, Johannes Lampe, Nichola Cooper, Peter Kießling, & Ann Gardulf. (2024). Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis. Journal of Comparative Effectiveness Research. 13(9). e230171–e230171. 3 indexed citations

Menon, Deepak, et al.. (2024). Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis. Neurology. 103(4). e209722–e209722. 3 indexed citations

Bril, Vera, John Vissing, Artur Drużdż, et al.. (2023). Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies. Journal of the Neurological Sciences. 455. 122016–122016. 1 indexed citations

Pasnoor, Mamatha, Vera Bril, Todd Levine, et al.. (2023). Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. European Journal of Neurology. 30(5). 1417–1424. 2 indexed citations

Antozzi, Carlo, Jeffrey T. Guptill, Vera Bril, et al.. (2023). Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis. Neurology. 102(2). e207937–e207937. 30 indexed citations

10.

Barnett, Carolina, et al.. (2023). Clinical characteristics and treatment outcomes in patients with double‐seronegative myasthenia gravis. European Journal of Neurology. 31(1). e16022–e16022. 9 indexed citations

11.

Nowak, Richard J., Ari Breiner, Vera Bril, et al.. (2023). Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open‐label extension. Annals of Clinical and Translational Neurology. 11(1). 194–206. 11 indexed citations

12.

Idiáquez, Juan, et al.. (2023). Reliability of confocal corneal microscopy for measurement of dendritic cell density in suspected small fiber neuropathy. Muscle & Nerve. 68(4). 460–463. 2 indexed citations

13.

Menon, Deepak & Vera Bril. (2022). Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals. Drugs. 82(8). 865–887. 81 indexed citations

14.

Merkies, Ingemar S. J., Ivo N. van Schaik, Vera Bril, et al.. (2022). Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy. Journal of the Peripheral Nervous System. 27(2). 159–165. 5 indexed citations

15.

Menon, Deepak, et al.. (2021). Practical Aspects of Transitioning from Intravenous to Subcutaneous Immunoglobulin Therapy in Neuromuscular Disorders. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(2). 161–167. 6 indexed citations

16.

Menon, Deepak, Carolina Barnett, Joy Vijayan, et al.. (2021). Telephone consultation for myasthenia gravis care during the COVID‐19 pandemic: Assessment of a novel virtual myasthenia gravis index. Muscle & Nerve. 63(6). 831–836. 11 indexed citations

17.

Menon, Deepak, et al.. (2021). Pilot study of a novel transmembranous electromyography device for assessment of oral cavity and oropharyngeal muscles. Muscle & Nerve. 65(3). 303–310. 3 indexed citations

18.

Menon, Deepak, Hans Katzberg, Carolina Barnett, et al.. (2021). Thymoma pathology and myasthenia gravis outcomes. Muscle & Nerve. 63(6). 868–873. 14 indexed citations

19.

Bril, Vera, J. England, Gary M. Franklin, et al.. (2011). Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]. Neurology. 76(20). 1758–1765. 449 indexed citations breakdown →

20.

Perkins, Bruce A., Madeline Ngo, & Vera Bril. (2002). Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy. Muscle & Nerve. 25(2). 212–212. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact